Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
Alcoholic cirrhosis outpaces non-alcoholic cirrhosis in use of resources
WASHINGTON — Patients with alcohol-associated cirrhosis required more health care resource utilization, including hospital stays, than patients with non-alcoholic cirrhosis, according to findings presented at The Liver Meeting 2017.
Healio to provide live coverage of The Liver Meeting 2017
WASHINGTON — Beginning Friday, October 20, Healio Gastroenterology and Liver Disease will provide live coverage from the The Liver Meeting 2017.
Log in or Sign up for Free to view tailored content for your specialty!
Liver pressure has 'come of age,' aids management of liver disease
ORLANDO — Measuring hepatic pressure should be done by gastroenterologists and hepatologists because it can best direct treatment and outcomes, according to an international expert at the World Congress of Gastroenterology at ACG 2017.
Hospice care may come too late for patients with chronic liver disease
Patients with chronic liver disease, such as nonalcoholic fatty liver disease, alcoholic liver disease and chronic hepatitis C, had significantly longer hospital length of stay, annual health care charges and shorter hospice length of stay compared with other patients, according to recently published data.
Ascites pump reduces need for large volume paracentesis
A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to transjugular intrahepatic portosystemic shunt, or TIPS, according to a recently published study.
Viekira Pak safe for patients with HCV, Child-Pugh A cirrhosis
Patients with hepatitis C and Child-Pugh A cirrhosis had similar rates of treatment-related adverse events and lower rates of hepatic decompensation after treatment with Viekira Pak compared with untreated patients, according to recently published data. However, those with a history of advanced cirrhosis were more likely to experience treatment-related adverse events.
Muscle volume loss correlated with increased mortality in cirrhosis
Among patients with cirrhosis, muscle volume loss and hepatocellular carcinoma within Milan criteria were prognostic factors for mortality, according to recently published data.
Cardiac complications may predict mortality from cirrhosis
Cardiovascular complications — including increased left atrial dimension and heart rate and reduced mean arterial pressure — may predict an increased risk for mortality among patients with cirrhosis, according to a recently published study.
Statins may reduce mortality, decompensation in alcoholic cirrhosis
The use of statins in patients with alcoholic cirrhosis reduced the rates of both mortality and decompensation, according to recently published data.
C-reactive protein predicts mortality, readmission in patients with cirrhosis
C-reactive protein levels at hospital discharge significantly predicted readmission and 6-month mortality among patients with cirrhosis after hospitalization for bacterial or fungal infections, according to a recently published study.